Chandra A Reynolds
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (7)
Alzheimer’s disease (AD) is the most common cause of dementia, with global case numbers projected to reach 153 million in 2050 1 . AD is highly heritable, with twin-based heritability estimates of 60-80% 2 . While 1,200 causal loci are predicted to exist for AD 3 , approximately 80 have been associated with AD in two recent studies 4,5 , suggesting that many loci remain to be discovered 6 . Here, we analyzed data from 183,620 AD cases and 2.6 million controls from diverse ancestries, identifying 118 loci in a multi-ancestry analysis and 9 additional loci in ancestry-specific analyses, 48 of which are new. We identified new AD risk genes, prioritized potential drug targets, and identified microglia and, for the first time, several neuronal cell types enriched for AD-associated genetic risk. Moreover, we improved polygenic prediction and estimated a single-nucleotide polymorphism (SNP) heritability of 19%. Together, our findings offer insights into the genetic architecture and potential pathobiology of AD, as well as specific targets for future drug development research.
Year:
2025
Epigenetic aging prior to midlife is gaining interest as an intervenable period to address health and cognitive aging. Epigenetic changes may index DNA methylation aging rates, but methylation profiles may not be substitutable across tissues. We compared DNA methylation clocks and age acceleration in saliva, buffy coat (BC), and peripheral blood mononuclear cells (PBMC) collected in 91 individuals (7 unpaired, 20 siblings, 64 twins; 18 monozygotic (MZ), 14 dizygotic (DZ) pairs) from the Colorado Adoption/Twin Study of Lifespan behavioral development and cognitive aging (CATSLife1; Mean age=30.90 years [range=28.07–41.13]; 50.5% female). Across 15 DNA methylation clocks, chronological age and DNA methylation ages were moderately associated (Mean Spearman correlations: r =0.36, Saliva; r =0.41, BC; r =0.36, PBMC). In mixed-effects models, saliva showed higher DNA methylation ages ( B =3.83–16.46 years vs BC, p <0.001), whereas PBMC and BC were comparable ( B =-0.06–0.39 years vs BC, p ≥0.447). The exception was the next-generation clock DunedinPace showing comparability ( p =0.486). Similar patterns were observed for age acceleration estimates. Altogether, MZ pairs (meta-analytic r= 0.48, 95%CI=0.30,0.65) and DZ pairs (meta-analytic r= 0.38, 95%CI=0.29,0.46) were moderately correlated (Spearman), but MZ pairs showed heterogeneity across tissues ( p <0.020): saliva was lower (Mean r= 0.31, SD =0.24) than BC (Mean r= 0.63, SD =0.11) and PBMC (Mean r= 0.47, SD =0.19). Next-generation PCGrimAge and DunedinPace clocks showed consistent cross-tissue correlations within zygosity, while multi-tissue clocks (e.g., ZhangQ) showed comparable MZ-DZ correlations. While saliva-based DNA methylation is not a direct substitute for blood-based DNA methylation, BC and PBMC show comparability; nevertheless, all tissue types may be appropriate for DNA methylation aging studies when compared within tissues. Key Policy Highlights Saliva-based methylation is not a direct substitute for blood-based methylation. Saliva-based DNA methylation clocks demonstrated relatively older methylation ages and faster age accelerations relative to blood-based DNA methylation clocks. Blood-based DNA methylation clocks were comparable across buffy coat and peripheral blood mononuclear cell tissues. Twin similarity, particularly among identical twins, was higher for blood-based DNA methylation clocks and newer generation DNA methylation clocks. Three clocks (one first-generation multi-tissue and two next-generation) showed consistency and/or comparability across tissues and showed moderate to strong correlations among identical and fraternal twins, supporting the importance of tool development.
Year:
2025
Background Polygenic scores (PGSs) may help assess genetic predisposition to multifactorial traits. We examined whether age, sex, and leisure-time physical activity (LTPA) modify the association between a PGS for handgrip strength (HGS) and measured HGS in older adults. Methods PGS HGS, based on Pan-UK Biobank GWAS data, was calculated for 5103 participants (aged 40–96; 44% women) from eight twin cohorts in Denmark, Sweden, Australia, the United States, and Finland within the IGEMS consortium. Sex-standardized HGS and self-reported LTPA were assessed cross-sectionally. Linear mixed models estimated associations between PGS and HGS, including interactions with age, country, and LTPA, as well as an association between PGS and LTPA. Fixed-effect within-pair models were conducted to assess environmental contributions. Results Higher PGS was associated with greater HGS (β = 2.14, SE = 0.15, p < 0.001), explaining 4.6% of HGS variance overall, with modest variation across countries. In sex-stratified models, PGS explained 5.2% of the variance in females and 4.3% in males. A significant PGS × LTPA interaction (β = –0.034, p = 0.013) indicated that LTPA had a stronger effect among individuals with lower PGS HGS. No statistically significant interaction with age was found. The within-pair models offered limited support for the environmental impact of LTPA. Conclusions PGS for HGS was associated with measured HGS, with effect modification by LTPA. Findings provide some evidence that physical activity may buffer against genetic predisposition to lower HGS. The results highlight the potential of PGSs to capture individual differences in strength-related traits across populations.
Year:
2025
INTRODUCTION Repeated cognitive testing can boost scores due to practice effects (PEs). It remains unclear whether PEs persist across multiple follow-ups and long durations. We examined PEs across multiple assessments from midlife to old age in a nonclinical sample. METHOD Men (N=1,608) in the Vietnam Era Twin Study of Aging (VETSA) underwent neuropsychological assessment across 4 waves from mean age 56 to 74. We leveraged age-matched attrition-replacement (AR) participants to estimate PEs at each wave. We compared cognitive trajectories and prevalence of mild cognitive impairment (MCI) using unadjusted versus PE-adjusted scores. RESULTS Across follow-ups, a range of 7-12 out of 30 measures demonstrated significant PEs, especially in episodic memory and visuospatial domains. Adjusting for PEs resulted in steeper cognitive decline with up to 29% higher MCI prevalence. DISCUSSION PEs persist across multiple assessments and decades. The AR-participant method provides accurate sample-specific PE estimates that enable significantly earlier detection of MCI.
Year:
2025
Background and Objectives The association between subjective and objective memory in established adulthood and midlife remains understudied, despite its potential importance for early cognitive health interventions. This study examined their convergence in adults aged 28–51, characterizing objective memory through performance level, change, and variability. Furthermore, we explored how sociodemographic and psychological factors moderate the subjective-objective memory convergence, aiming to elucidate the complex interplay between perceived and actual cognitive function in these critical life stages. Research Design and Methods Adults in established adulthood and midlife (N = 415, Mage = 35.96, range: 28–51, % female = 59.28%) completed smartphone-based momentary cognitive assessments 3 times a day for up to 14 days. After the conclusion of the assessments, the participants completed a wrap-up survey, including an objective memory measurement. To quantify characteristics of objective memory performance, we used Bayesian mixed-effect location-scale models and modeled intraindividual variability. Results Better initial memory performance and improvement over time predicted enhanced subjective memory performance assessments in naturalistic settings, with objective memory change emerging as the strongest predictor. Notably, intraindividual variability in objective memory showed no systematic relationship with subjective evaluations, and psychological and sociodemographic variables did not moderate the objective-subjective memory performance relationship. Discussion and Implications These findings highlight the complexity of subjective-objective memory performance relationships in established adulthood. Our results demonstrate the utility of smartphone-based momentary assessments for capturing both longitudinal trajectories and day-to-day variability in cognitive performance. This methodology offers promising opportunities for studying cognitive function in naturalistic settings during established adulthood, potentially contributing to our understanding of early cognitive changes across the lifespan.
Year:
2025
People who are higher in conscientiousness, extraversion, and agreeableness, and lower in neuroticism tend to live longer. The present research tested the hypothesis that personality trait change in middle and older adulthood would also be associated with mortality risk, above and beyond personality trait level. Personality trait change may causally influence mortality risk through corresponding changes in health behaviors, social processes, and stress experience. Alternatively, personality trait change may be a marker of successful or unsuccessful adaptation to life circumstances, which in turn influences mortality risk, or shared risk factors may impact personality trait change and mortality risk. In the latter case, personality trait change may serve as a “psychosocial vital sign” pointing toward increased risk. In 11 samples of middle-aged and older adults (combined N = 32,348), we used multilevel growth curve models to estimate personality trait level and personality trait change across 3-11 measurement occasions spanning 6-43 years. Next, we used Cox proportional hazards models to test whether personality trait level and personality trait change were associated with mortality risk. Higher conscientiousness (hazard ratio [HR] = 0.83), extraversion (HR = 0.93), and agreeableness (HR = 0.88) were associated with longer survival, while higher neuroticism was associated with shorter survival (HR = 1.22). In contrast to personality trait level, we found limited evidence for associations between personality trait change and mortality risk. We discuss conceptual and methodological implications of the present findings that may guide future research on associations between personality trait change, health, and mortality.
Year:
2024
Objectives Frailty is not an end state of aging, but rather represents physiological vulnerability across multiple systems that unfolds across adulthood. However, examinations of frailty at the midlife transition, and how frailty may impact other age-sensitive traits, such as processing speed (PS), remain scarce. Our research aims were to examine frailty and frailty-speed associations before midlife, a ripe developmental period for healthy aging interventions. Methods Using data from the Colorado Adoption/Twin Study of Lifespan behavioral development and cognitive aging (N = 1,215; Mage = 33.23 years; standard deviation = 4.98), we constructed 25-item (FI25) and 30-item (FI30) frailty indices. PS was measured using the Colorado Perceptual Speed task and WAIS-III Digit Symbol (DS) subtest. Multilevel models accounted for clustering among siblings and adjusted for sex, race, ethnicity, adoption status, educational attainment, and age. Results Reliability of FI measures was apparent from strong intraclass correlations (ICCs) among identical twin siblings, although ICC patterns across all siblings suggested that FI variability may include nonadditive genetic contributions. Higher FI was associated with poorer PS performance but was significant for DS only (BFI25 = −1.17, p = .001, d = −0.12; BFI30 = −1.21, p = .001, d = −0.12). Furthermore, the negative frailty-DS association was moderated by age (BFI25×age = −0.14, p = .042; BFI30×age=−0.19, p = .008) where increasingly worse performance with higher frailty emerged at older ages. Discussion Frailty is evident before midlife and associated with poorer PS, an association that magnifies with age. These findings help elucidate the interrelationship between indicators of frailty and cognitive performance for adults approaching midlife, an understudied period within life-span development.
Year:
2023
Collaborators (47)
LUKE EVANS
University of Colorado Boulder
Ruth Frikke-Schmidt
Professor, Chief Physician, MD PhD DMSc
-
Emily C. Willroth
Washington University in St. Louis
Harro Seelaar
Neurologist
Erasmus MC
Anbupalam Thalamuthu
University of New South Wales
Paul O'Reilly
Associate Professor
Icahn School of Medicine at Mount Sinai
Margaret Gatz
Professor of Psychology
University of Southern California
Matthew Panizzon
Professor
University of Washington
Deborah Finkel
Professor
Jönköping University
Clive Ballard
Pro-Vice Chancellor and Executive Dean
University of Exeter
Päivi Herranen
University of Jyväskylä
Robert A. Rissman
Professor and Director
University of Southern California
Elizabeth Muñoz
Associate Professor
University of Texas at Austin
Pieter Jelle Visser
Karolinska Institutet
Daniel Mroczek
Professor
Northwestern University
Arvid Rongve
Professor
University of Bergen
Betty Tijms
Senior researcher
VU medisch centrum
Martijn Huisman
University of Amsterdam
Katja Scheffler
Associate Professor
Norwegian University of Science and Technology
Ida Karlsson
Karolinska Institutet
Geert Jan Biessels
Professor of Neurology
University Medical Center Groningen
Sara Hägg
Senior Researcher
Karolinska Institutet
Mohsen Ghanbari
Associate professor
Erasmus MC
Avron Spiro III
Research Professor
boston university chobanian and avedisian school of medicine
Lasse Pihlstrøm
Professor
University of Oslo
Byron Creese
Senior Lecturer & Director of Research
Brunel University London
Jens Hjerling Leffler
Karolinska Institutet
Thomas Truelsen
University of Copenhagen
Christian Erikstrup
Chair Professor
Aarhus University
Wiesje van der Flier
Scientific director
VU medisch centrum
Alessandro Serretti
Docenti di ruolo di IIa fascia
Università degli Studi di Enna Kore
Dan Rujescu
Head of Clinical Division of General Psychiatry
Medical University of Vienna
D.P. Wightman
University of Amsterdam
Thomas Folkmann Hansen
Professor
Technical University of Denmark
Jeremy Elman
Associate Professor
University of California San Diego School of Medicine
Denis Gerstorf
Professor
Humboldt-Universität zu Berlin
Jian Zeng
The University of Queensland
Eileen K Graham
Northwestern University
Nancy Pedersen
Karolinska Institutet
Ole A. Andreassen
Oslo University Hospital
Elina Sillanpää
Associate professor of health promotion (tenure track)
University of Jyväskylä
Teemu Palviainen
University of Helsinki
Jaakko Kaprio
Research Director
University of Helsinki
Taina Rantanen
Professor
University of Jyväskylä
Ryan Bruellman
University of California, Riverside
Marianne Nygaard
University of Southern Denmark
Frank J. Wolters
Associate professor
Erasmus University Rotterdam
Make your next move.
Prepare your application
Review drafts before you send them.